Management of hyperlipidemias: an update

Area of Science:

• Biochemistry
• Pharmacology
• Metabolic Diseases

Background:

• Cholesterol biosynthesis enzymes, receptors, and transporters are key to understanding lipid and lipoprotein pathways.
• This knowledge has facilitated the development of numerous lipid-lowering medications.
• Lipid derangements can manifest with specific dermatologic symptoms.

Purpose of the Study:

• To review cholesterol metabolism pathways and their dermatologic implications.
• To examine current and emerging lipid-lowering drugs targeting intestinal and hepatic processes.
• To explore future therapeutic targets and the role of traditional foods in lipid management.

Main Methods:

• Recapitulation of cholesterol metabolism pathways.
• Review of drugs affecting intestinal cholesterol and bile-acid reabsorption.
• Examination of hepatic lipoprotein biosynthesis and catabolism.
• Literature review for future therapeutic targets and dietary interventions.
• Discussion of current National Cholesterol Education Program guidelines.

Main Results:

• Established pathways of cholesterol metabolism and their clinical relevance.
• Overview of pharmacological interventions for hypercholesterolemia.
• Identification of potential new targets in lipid metabolism.
• Consideration of traditional foods as adjunct lipid-lowering agents.

Conclusions:

• Advances in understanding cholesterol metabolism have driven the development of effective lipid-lowering therapies.
• Future research should focus on novel therapeutic targets and the integration of dietary strategies.
• Adherence to updated clinical guidelines is essential for optimal hypercholesterolemia management.